Accelerating China, Covidien Establishes JV With Changzhou Kangdi
This article was originally published in PharmAsia News
Irish device maker Covidien has set up a joint venture with Changzhou Kangdi to capture the value segment in China’s vast lower-tier market.
You may also be interested in...
Covidien acquired a privately held manufacturer of electrosurgical generators based in Ribeirao Preto, Brazil, and established a joint venture with a manufacturer of open stapler products based in Kiangsu Province in China, to access patients who can’t afford top-tier hospitals in those countries.
Brazilian Presidential Decree Opens Door To Less Stringent GMP Certification Requirements For Foreign Firms
New decree opens door to more lenient good manufacturing practice certification requirements than are currently imposed on international medical device manufacturers seeking to gain market entry in Brazil.
As Chinese returnees transform their startups to fully-fledged biopharma operations with a full product lineup and the global market in sight, the journey has been filled with challenges. Based on interviews and on-the-ground reporting, this new series takes a closer look at several companies' experiences.